Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves.

The objective of this study was to evaluate the capacity of three clinically useful tissue sources: tricuspid valve leaflet (TVL), carotid artery (CA), and jugular vein (JV), to generate myofibroblasts for potential use in a tissue-engineered cardiac valve replacement. Tissue biopsies of clinically appropriate sizes obtained from juvenile sheep were used for this work. Cells obtained from all three tissue sources exhibited a myofibroblast phenotype in vitro, as demonstrated by their immunoreactivity with antibodies directed against vimentin, alpha-smooth muscle actin, fibronectin, and chondroitin sulfate. Protein synthesis characteristics were defined for the key extracellular matrix components: collagen, glycosaminoglycans, and elastin. Among the three sources, JV generated the highest numbers of cells, and JV cells produced the largest amount of collagen per cell. These data suggest that venous tissue, with its relative ease of accessibility, may generate myofibroblasts potentially useful for the interstitial cellular component of a tissue-engineered cardiac valve.

[1]  Chrysanthi Williams,et al.  Cell sourcing and culture conditions for fibrin-based valve constructs. , 2006, Tissue engineering.

[2]  H. Alexander,et al.  Development and characterization of tissue-engineered aortic valves. , 2001, Tissue engineering.

[3]  F J Schoen,et al.  Tissue-engineered valved conduits in the pulmonary circulation. , 2000, The Journal of thoracic and cardiovascular surgery.

[4]  R. Guyton,et al.  Pregnancy and valvular heart disease. , 2005, The heart surgery forum.

[5]  R. Nerem,et al.  Hemodynamic influences on vascular endothelial biology. , 1990, Toxicologic pathology.

[6]  R Langer,et al.  Tissue-engineered heart valve leaflets: does cell origin affect outcome? , 1997, Circulation.

[7]  Robert M. Nerem,et al.  Oscillatory shear stress and hydrostatic pressure modulate cell-matrix attachment proteins in cultured endothelial cells , 2007, In Vitro Cellular & Developmental Biology - Animal.

[8]  F J Schoen,et al.  Tissue engineering of heart valves: in vitro experiences. , 2000, The Annals of thoracic surgery.

[9]  Simon P. Hoerstrup,et al.  Tissue Engineering of Functional Trileaflet Heart Valves From Human Marrow Stromal Cells , 2002, Circulation.

[10]  M. Thubrikar,et al.  Structure, stress, and tissue repair in aortic valve leaflets. , 1988, Cardiovascular research.

[11]  B L Bass,et al.  Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. , 1994, The Journal of surgical research.

[12]  Diane Hoffman-Kim,et al.  Tricuspid valve biopsy: a potential source of cardiac myofibroblast cells for tissue-engineered cardiac valves. , 2003, The Journal of heart valve disease.

[13]  N. Blumenkrantz,et al.  An assay for hydroxyproline and proline on one sample and a simplified method for hydroxyproline. , 1975, Analytical biochemistry.

[14]  Magdi H Yacoub,et al.  Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. , 2002, The Journal of heart valve disease.

[15]  Robert M Nerem,et al.  Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells. , 2004, The Journal of heart valve disease.

[16]  R. Brentani,et al.  A simple and sensitive method for the quantitative estimation of collagen. , 1979, Analytical biochemistry.

[17]  Frederick J Schoen,et al.  Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. , 2002, The Journal of heart valve disease.

[18]  R. Hopkins.  Cardiac Reconstructions with Allograft Tissues , 2004 .

[19]  V. Ferrans,et al.  Morphology: Allograft Heart Valves , 2005 .

[20]  M A Moses,et al.  Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous cell seeding. , 2000, The Journal of thoracic and cardiovascular surgery.

[21]  A. Seifalian,et al.  Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices? , 2006, Expert review of medical devices.

[22]  R. Sodian,et al.  Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofibroblasts. , 2001, The Thoracic and cardiovascular surgeon.

[23]  S. Hoerstrup,et al.  Fluorescence activated cell sorting: a reliable method in tissue engineering of a bioprosthetic heart valve. , 1998, The Annals of thoracic surgery.

[24]  T. Shinoka.  Tissue engineered heart valves: autologous cell seeding on biodegradable polymer scaffold. , 2002, Artificial organs.

[25]  S. Hoerstrup,et al.  Tissue engineering of a bioprosthetic heart valve: stimulation of extracellular matrix assessed by hydroxyproline assay. , 1999, ASAIO journal.

[26]  S. Hoerstrup,et al.  Tissue engineering in cardiovascular surgery: MTT, a rapid and reliable quantitative method to assess the optimal human cell seeding on polymeric meshes. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[27]  R. Nerem,et al.  Tissue engineering a blood vessel: Regulation of vascular biology by mechanical stresses , 1994, Journal of cellular biochemistry.

[28]  Simon P. Hoerstrup,et al.  Scaffold Precoating with Human Autologous Extracellular Matrix for Improved Cell Attachment in Cardiovascular Tissue Engineering , 1999 .

[29]  R M Nerem,et al.  The study of the influence of flow on vascular endothelial biology. , 1998, The American journal of the medical sciences.

[30]  B Glasmacher,et al.  In vitro modelling of tissue using isolated vascular cells on a synthetic collagen matrix as a substitute for heart valves. , 2001, The Thoracic and cardiovascular surgeon.

[31]  D. Mooney,et al.  Engineered smooth muscle tissues: regulating cell phenotype with the scaffold. , 1999, Experimental cell research.

[32]  G. Jundt,et al.  In situ measurement of collagen synthesis by human bone cells with a Sirius Red-based colorimetric microassay: effects of transforming growth factor β2 and ascorbic acid 2-phosphate , 1999, Histochemistry and Cell Biology.

[33]  Robert M Nerem,et al.  Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. , 2006, Tissue engineering.

[34]  John Fisher,et al.  Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. , 2002, The Journal of heart valve disease.

[35]  Simon P Hoerstrup,et al.  A new source for cardiovascular tissue engineering: human bone marrow stromal cells. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.